Authored by David Christopher via Bankless.com,
CME wants Kalshi's Bitcoin perp reclassified as a swap, not banned. That distinction reveals what's actually at stake in the CFTC lawsuit.
Yesterday, CME, the country's dominant derivatives exchange, sued the CFTC over its recent approval of regulated crypto perpetual futures.
The exchange argues Kalshi's Bitcoin perp should be treated as a swap, not a futures contract, a classification shift that would push the product into a more restrictive, institution-facing rulebook. The CFTC called the suit "frivolous" and said it looks forward to dismissing it.
We've known for some time that major exchanges like CME and ICE have grown uneasy about the rise of perpetuals, an unease already visible in their push to have regulators scrutinize Hyperliquid over manipulation, sanctions evasion, anything they can find.
Why? Because regulators have finally opened a compliant path for Americans to trade an entirely new class of derivatives, one whose financial efficiency threatens the effectively monopolistic business model of these incumbents.
The Label Is the Business Model
CME's legal argument turns on a label.
If Kalshi's Bitcoin perp is a futures contract, it can trade on a regulated futures exchange, where regular U.S. users can access it. If it is a swap, it falls into a heavier rulebook built largely for institutional derivatives, making it harder to launch, harder to distribute, and functionally out of reach for most retail traders.
That distinction sounds technical, and it echoes the same fight playing out over prediction markets, but the effect here is simple: whether perps will be accessible to retail users, or reserved primarily for institutional actors.
CME's filing comes wrapped in safety language, but, as always, the motivation is financial. Perps threaten the part of CME's business built around expiration.
A normal futures contract expires. To hold the same exposure, a trader has to roll into a new contract before it does. CME collects another round of trading and clearing fees on every roll, and that churn feeds the market data business it sells on top.
A perpetual future doesn't expire. A trader holds the same position open indefinitely and settles periodic funding payments instead of rolling.
No roll means no recurring trade, and that breaks a rhythm CME's business is built on. The market already understands the threat. When regulators opened the door to regulated U.S. perps, shares of CME, Cboe, and ICE fell as investors priced in real competition.
Why Perps Keep Gaining Ground
None of this makes perps harmless. They can involve leverage, liquidations, and funding costs that quietly eat into a position over time. CME CEO Terry Duffy is right that many retail traders don't fully understand those risks, and the venues offering perps should do the work to make them clear.
But blocking regulated U.S. perps does not make demand disappear. It pushes Americans back offshore, where they get fewer disclosures, weaker oversight, and less protection when something breaks.
That is why the better answer is to regulate the instrument clearly: leverage limits, margin standards, and liquidation transparency.
Crypto is where this starts because the markets are already mature. That makes Bitcoin perps the easiest place for regulators to begin. But given the demand we've seen with HIP-3, it won't be long before the model stretches to stocks, indices, and ETFs.
That is what makes CME's lawsuit so revealing. The exchange is asking for a reclassification, not a ban. You do not do that to a product you think you can kill. If you can kill it, you kill it. If you can't, you relocate it, cut it off to slow the bleed.
This is the history of crypto. A better technology emerges, users are drawn to its merits, incumbents call it dangerous, and the regulatory fight begins. Those fights have rarely decided whether the old model gets protected. They simply decide how long.
The Perpification has already begun, and all incumbents can hope to do is slow it down.